Cain Brothers vs Healthios Capital
Comparing two boutique M&A advisors · Last updated April 12, 2025
| Attribute | Cain Brothers | Healthios Capital |
|---|---|---|
| Type | Industry specialist | Industry specialist |
| HQ | New York, NY | Chicago, IL |
| Founded | 1982 | 2009 |
| Sector focus | Healthcare Services | Healthcare Services |
| Deal size | $25M-$500M | $10M-$150M |
| Senior team |
|
|
| Rating | Locked | Locked |
| Reviews | 0 verified | 0 verified |
Choosing between Cain Brothers and Healthios Capital
Cain Brothers and Healthios Capital both work in Healthcare Services. Founders running a sell-side process in those categories often see both names on their advisor longlist, which is why this comparison comes up. Both firms position themselves as industry specialist advisors, so the choice is less about category and more about pattern recognition, senior attention, and process fit.
Cain Brothers is headquartered in New York, NY and was founded in 1982, while Healthios Capital operates out of Chicago, IL and was founded in 2009. Geography matters here: Cain Brothers's New York relationships and Healthios Capital's Chicago relationships will overlap on national strategics but diverge on the regional private equity buyer set most likely to push price. On deal-size focus, Cain Brothers states $25M-$500M while Healthios Capital states $10M-$150M.
For founders deciding between Cain Brothers and Healthios Capital, the honest recommendation is to take a working session with each named partner before signing. Read the firm-level reviews on BankerNotes for the pattern that matters most: did the partner who pitched the mandate run the buyer calls and final negotiations, or did the work slide down the org chart by week six. That pattern, more than league-table position, is what separates a good outcome from a mediocre one.
Cain Brothers is a industry specialist headquartered in New York, NY and founded in 1982. The firm focuses on Healthcare Services and typically advises on transactions in the $25M-$500M range. Key dealmakers include Fred...
Healthios Capital is a industry specialist headquartered in Chicago, IL and founded in 2009. The firm focuses on Healthcare Services and typically advises on transactions in the $10M-$150M range. Key dealmakers include S...
Frequently asked questions
- What is the main difference between Cain Brothers and Healthios Capital?
- Cain Brothers is a industry specialist HQ'd in New York, NY (founded 1982), focused on Healthcare Services, with a typical deal range of $25M-$500M. Healthios Capital is a industry specialist HQ'd in Chicago, IL (founded 2009), focused on Healthcare Services, with a typical deal range of $10M-$150M. Beyond those facts, the most reliable differentiator is senior banker attention, which BankerNotes reviews are designed to surface.
- Which firm has better founder reviews, Cain Brothers or Healthios Capital?
- Cain Brothers's current rating is Locked (reviews unlock after five verified founders submit ratings). Healthios Capital's current rating is Locked (reviews unlock after five verified founders submit ratings). Read the individual firm profiles for the full review breakdown.
- Should I shortlist both Cain Brothers and Healthios Capital?
- For most founders evaluating sell-side advisors with overlapping sector and deal-size fit, putting both on a shortlist is reasonable. The point of a bake-off is to test how the senior team behaves under pressure, how the firm shapes the buyer universe, and how it handles a difficult diligence question. Treat the shortlist as an interview, not a beauty contest.
- How does BankerNotes verify reviews of Cain Brothers and Healthios Capital?
- Every review is submitted by a founder who confirms they hired the firm as their sell-side advisor. We verify the reviewer privately using work email, LinkedIn, and approximate engagement timing. The verified identity is never published. Only the rating, written review, and a generic sector label appear on the public page.
Related advisor comparisons
Browse sectors covered
Last updated: April 12, 2025